Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Merolla

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
International Journal of Cancer|May 1, 2013
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cellsErika Martinelli, Teresa Troiani, Elena D'Aiuto, et al.
International Journal of Cancer|October 11, 2014
New therapeutic perspectives in CCDC6 deficient lung cancer cellsFrancesco Morra, Chiara Luise, Roberta Visconti, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2015
TLR4 down-regulation identifies high risk HPV infection and integration in head and neck squamous cell carcinomasGiuseppe Pannone, Pantaleo Bufo, Mirella Pace, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining MethodLorenzo Nibid, Erica Iannaccone, Elisabetta Maffei, et al.
Biomolecules|January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal MelanomaMichele Massimino, Elena Tirrò, Stefania Stella, et al.
Cancer Research Communications|December 19, 2025
CCDC6 immunostaining in conjunction with the Rad51 HRD assay may expand PARPi treatment eligibility in HGSOC patientsDaniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
International Journal of Cancer|May 1, 2013
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cellsErika Martinelli, Teresa Troiani, Elena D'Aiuto, et al.
International Journal of Cancer|October 11, 2014
New therapeutic perspectives in CCDC6 deficient lung cancer cellsFrancesco Morra, Chiara Luise, Roberta Visconti, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2015
TLR4 down-regulation identifies high risk HPV infection and integration in head and neck squamous cell carcinomasGiuseppe Pannone, Pantaleo Bufo, Mirella Pace, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining MethodLorenzo Nibid, Erica Iannaccone, Elisabetta Maffei, et al.
Biomolecules|January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal MelanomaMichele Massimino, Elena Tirrò, Stefania Stella, et al.
Cancer Research Communications|December 19, 2025
CCDC6 immunostaining in conjunction with the Rad51 HRD assay may expand PARPi treatment eligibility in HGSOC patientsDaniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, et al.
Pageof 7